1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Pathological Gambling Global Clinical Trials Review, H2, 2015

Pathological Gambling Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Pathological Gambling Global Clinical Trials Review, H2, 2015" provides an overview of Pathological Gambling clinical trials scenario. This report provides top line data relating to the clinical trials on Pathological Gambling. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Pathological Gambling Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Pathological Gambling to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Pathological Gambling to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Pathological Gambling Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profile Snapshots 24
Appendix 37
Abbreviations 37
Definitions 37
Research Methodology 38
Secondary Research 38
About GlobalData 39
Contact Us 39
Disclaimer 39
Source 40

List of Tables
Pathological Gambling Therapeutics, Global, Clinical Trials by Region, 2015* 5
Pathological Gambling Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Pathological Gambling Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Pathological Gambling Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9
Pathological Gambling Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Pathological Gambling Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 11
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 12
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 15
Pathological Gambling Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Pathological Gambling Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Pathological Gambling Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Pathological Gambling Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Pathological Gambling Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 20
Pathological Gambling Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Pathological Gambling Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Pathological Gambling Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

List of Figures
Pathological Gambling Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Pathological Gambling Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Pathological Gambling Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Pathological Gambling Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9
Pathological Gambling Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Pathological Gambling Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 11
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 12
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Pathological Gambling Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Pathological Gambling to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 15
Pathological Gambling Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Pathological Gambling Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Pathological Gambling Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Pathological Gambling Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 19
Pathological Gambling Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 20
Pathological Gambling Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Pathological Gambling Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Pathological Gambling Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 38

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Residential Substance Abuse and Mental Health Facilities Global Market Report 2017

Residential Substance Abuse and Mental Health Facilities Global Market Report 2017

  • $ 4000
  • Industry report
  • December 2016
  • by TBRC Business Research

Residential substance abuse and mental health facilities provide medical services, room, board, supervision and counseling services to patients suffering from mental illness or substance abuse. Residential ...

Family Counseling & Crisis Intervention Services in the US - Industry Market Research Report

Family Counseling & Crisis Intervention Services in the US - Industry Market Research Report

  • $ 1020
  • Industry report
  • October 2016
  • by Ibisworld

Staying positive: Funding will slow, but steady demand will maintain growth Family Counseling & Crisis Intervention Services in the US The Family Counseling and Crisis Intervention Services industry provides ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.